<SEC-DOCUMENT>0001628280-22-021916.txt : 20220809
<SEC-HEADER>0001628280-22-021916.hdr.sgml : 20220809
<ACCEPTANCE-DATETIME>20220809160504
ACCESSION NUMBER:		0001628280-22-021916
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		46
CONFORMED PERIOD OF REPORT:	20220809
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220809
DATE AS OF CHANGE:		20220809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neoleukin Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001404644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36327
		FILM NUMBER:		221148201

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 360 - 1616 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-732-2133

	MAIL ADDRESS:	
		STREET 1:		SUITE 360 - 1616 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS, INC
		DATE OF NAME CHANGE:	20140128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS (USA) INC
		DATE OF NAME CHANGE:	20070626
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nltx-20220809.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:c58601b6-ee04-4714-9b16-329ba217a20a,g:a7533e54-1246-40d8-b41f-62c6a002fc07,d:212054e4e894495d9186b78e9939e7d8--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nltx-20220809</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8dbebb3f36b843008a868dd2c5a7ab1b_D20220809-20220809" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIxMjA1NGU0ZTg5NDQ5NWQ5MTg2Yjc4ZTk5MzllN2Q4L3NlYzoyMTIwNTRlNGU4OTQ0OTVkOTE4NmI3OGU5OTM5ZTdkOF80L2ZyYWc6MzdmNDJiOTYxZGNjNDZkYWFlNGZjMzM4OWQyNjBmZTYvdGFibGU6ZmEzNDA2NzUwYjkyNGI3ZmE5NDM5NDg0ODgzM2E3ZjkvdGFibGVyYW5nZTpmYTM0MDY3NTBiOTI0YjdmYTk0Mzk0ODQ4ODMzYTdmOV8yLTEtMS0xLTQ4MDgx_91bf0311-84a2-41b6-ac31-da53726b4998">0001404644</ix:nonNumeric><ix:nonNumeric contextRef="i8dbebb3f36b843008a868dd2c5a7ab1b_D20220809-20220809" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjIxMjA1NGU0ZTg5NDQ5NWQ5MTg2Yjc4ZTk5MzllN2Q4